C33
C33: Malignant neoplasm of trachea
Billable / specific codeICD-10-CM
C33 is a billable, specific ICD-10-CM code for malignant neoplasm of trachea. It is valid for submission on a claim.
Check C33 with the rest of the claim: free scrubberUse additional code
Add a secondary code to capture the detail described below.
Risk adjustment
C33 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 20 Lung and Other Severe Cancers1.136 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C33 is named in 73 Medicare coverage policies: 73 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52370Billing and Coding: Bevacizumab and biosimilars
- A52399Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®) and biosimilars
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
Code history
Unchanged in every release from FY2024 to FY2027.